HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Michel Pluot Selected Research

Michel Pluot Research Topics

Disease

10Neoplasms (Cancer)
05/2012 - 05/2003
4Adenocarcinoma
11/2004 - 05/2003
2Carcinoma (Carcinomatosis)
11/2014 - 01/2004
2Glioma (Gliomas)
11/2008 - 10/2007
2Melanoma (Melanoma, Malignant)
02/2007 - 12/2004
1Eosinophilia
01/2020
1Hydroa Vacciniforme
01/2012
1Myocarditis (Carditis)
03/2010
1Neoplasm Micrometastasis
02/2010
1Necrosis
11/2008
1Myocardial Infarction
12/2007
1Infections
12/2007
1Cardiovascular Infections
12/2007
1Glioblastoma (Glioblastoma Multiforme)
10/2007
1Neurodegenerative Diseases (Neurodegenerative Disease)
07/2006
1Squamous Cell Carcinoma of Head and Neck
06/2004
1Adenocarcinoma of Lung
05/2004
1Poisoning
05/2003

Drug/Important Bio-Agent (IBA)

3Proteins (Proteins, Gene)FDA Link
03/2010 - 11/2008
2Carcinoembryonic AntigenIBA
11/2014 - 05/2012
2DNA (Deoxyribonucleic Acid)IBA
11/2008 - 05/2003
2LipidsIBA
11/2008 - 07/2006
2AntigensIBA
12/2007 - 01/2004
2Member 1 Subfamily B ATP Binding Cassette TransporterIBA
11/2004 - 01/2004
2trioctyl phosphine oxide (TOPO)IBA
06/2004 - 05/2004
2Type I DNA Topoisomerases (Topoisomerase I)IBA
06/2004 - 05/2003
22- cyclohexylidenhydrazo- 4- phenyl- thiazoleIBA
05/2004 - 05/2003
1Aspartate Aminotransferases (Aspartate Transaminase)IBA
01/2020
1Creatine Kinase (Creatine Phosphokinase)IBA
01/2020
1StreptavidinIBA
11/2014
1Immunoglobulin G (IgG)IBA
11/2014
1Single-Domain AntibodiesIBA
11/2014
1Unsaturated Fatty Acids (Polyunsaturated Fatty Acids)IBA
01/2012
1Messenger RNA (mRNA)IBA
03/2010
1Capsid Proteins (Capsid Protein)IBA
03/2010
1Cytochromes c (Cytochrome c)IBA
03/2010
1Caspase 9IBA
03/2010
1AntibodiesIBA
02/2010
1phosphatidylethanolamineIBA
11/2008
1galactocerebrosideIBA
11/2008
1Oleic Acid (Oleate)IBA
11/2008
1i-cholesterolIBA
11/2008
1Phosphatidylcholines (Phosphatidylcholine)IBA
11/2008
1DystrophinIBA
12/2007
1Glycoproteins (Glycoprotein)IBA
12/2007
1ChromatinIBA
12/2007
1Granzymes (Granzyme)IBA
12/2007
1Hematoxylin (Haematoxylon)IBA
10/2007
1Matrix Metalloproteinase 14 (MT1-MMP)IBA
10/2007
1Eosine Yellowish-(YS) (Eosin)IBA
10/2007
1Phospholipids (Phosphatides)FDA LinkGeneric
10/2007
1CholesterolIBA
10/2007
1CollagenIBA
02/2007
1matrigelIBA
02/2007
1PlasminogenIBA
12/2004
1Cyclic AMP (AMP, Cyclic)IBA
12/2004
1Peptides (Polypeptides)IBA
12/2004
1Tissue Plasminogen Activator (Alteplase)FDA Link
12/2004
1Plasminogen Activators (Plasminogen Activator)IBA
12/2004
1Urokinase-Type Plasminogen Activator (Urokinase)FDA Link
12/2004
1type IV collagen alpha3 chain (Goodpasture antigen)IBA
12/2004
1Collagen Type IV (Type IV Collagen)IBA
12/2004
1Immunoglobulins (Immunoglobulin)IBA
11/2004
1Type II DNA Topoisomerases (Topoisomerase II)IBA
06/2004
19 alpha,11 alpha,15 alpha- trihydroxy- 16- phenoxy- 17,18,19,20- tetranorprosta- 4,5,13- trienoic acid (TPT)IBA
05/2004
1Topotecan (Hycamtin)FDA LinkGeneric
05/2004
1ParaffinIBA
01/2004
1Formaldehyde (Formol)FDA Link
01/2004
1Keratins (Keratin)IBA
01/2004
1LactonesIBA
05/2003
1LigandsIBA
05/2003
1Antineoplastic Agents (Antineoplastics)IBA
05/2003
1CamptothecinIBA
05/2003

Therapy/Procedure

2Quantum Dots (Quantum Dot)
11/2014 - 02/2010
2Therapeutics
10/2007 - 05/2003
1Ligation
03/2010
1Microspheres (Microsphere)
02/2010